Project: SCINUS: A novel BIOreactor for SCAlablE universal cell therapy manufacturing
Acronym | BIOSCALE (Reference Number: 114513) |
Duration | 01/09/2020 - 01/09/2023 |
Project Topic | We will deliver a validated prototype bioreactor (SCINUS) for scalable manufacturing of cell therapy (CT) products. Key objectives are: developing a disposable bioreactor container for culture of non-adherent cells and enhanced SCINUS cell culture sensing capabilities, process management and analytics, and validating SCINUS by optimizing production of a batch of mesenchymal stromal cells (MSCs) for treatment of type-1 diabetes at a clinical scale, and induced stem cells (iPSCs) at lab-scale. |
Network | Eurostars 2 |
Call | Eurostars Cut–off 13 |
Project partner
Number | Name | Role | Country |
---|---|---|---|
1 | MyCellHub N.V. | Partner | Belgium |
2 | NextCell Pharma AB | Partner | Sweden |
3 | Scinus Cell Expansion Netherlands B.V. | Coordinator | Netherlands |
4 | Sefar AG | Partner | Switzerland |